Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Jun 2019. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 224521000001111 | Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free 30 sachet | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 224541000001118 | Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free 30 sachet (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free 30 sachet | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free 30 sachet | Has VMP | Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | true | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free 30 sachet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free 30 sachet | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free 30 sachet | Has dispensed dose form | Drug powder | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free 30 sachet | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free 30 sachet | Has specific active ingredient | Magnesium alginate | true | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free 30 sachet | Has specific active ingredient | Sodium alginate | true | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free 30 sachet | Has NHS dm+d (dictionary of medicines and devices) freeness indicator | Sugar free | true | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free 30 sachet | Has dispensed dose form | Powder | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Gaviscon Infant oral powder sachets (Forum Health Products Ltd) 30 sachet | Is a | True | Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free 30 sachet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR